Combined cholesterol drugs for diabetes or metabolic syndrome
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study tests a combination of two cholesterol-lowering medicines (rosuvastatin and fenofibrate) for people with diabetes or metabolic syndrome who have unhealthy cholesterol levels. The goal is to see if taking both together works better than taking one alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 20 and 79 years old.
- You must have diabetes or have metabolic syndrome (at least three of these: belly fat, high triglycerides, low HDL (good cholesterol), high blood pressure, or high fasting blood sugar).
- Your cholesterol levels must be moderately high but not extremely high (LDL between 130 and 190 mg/dL, or triglycerides between 200 and 500 mg/dL with low HDL).
- You must not have had a heart attack, heart failure, or major valve disease in the past month.
- Your liver and kidney function must be within normal limits (not severe liver disease or kidney disease).
- You must not be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different ways of lowering cholesterol: a moderate statin (pitavastatin) plus another drug (ezetimibe) versus a stronger statin alone. The goal is to see which approach is safer regarding the risk of developing new diabetes.
This study looks at how your genes affect the way your body responds to rosuvastatin, a drug that lowers cholesterol. It aims to find the best dose for you based on your genetic makeup.
This trial compares a high-dose combination of rosuvastatin (a statin) and ezetimibe (another cholesterol-lowering drug) versus a standard rosuvastatin-only approach for people with peripheral artery disease (narrowed leg arteries) or widespread artery disease. The goal is to see which strategy better lowers LDL cholesterol and reduces heart and limb risks.
This trial compares a lower-dose cholesterol pill (rosuvastatin plus ezetimibe) to a higher-dose version of just rosuvastatin for people with mild to moderate heart artery blockages who have not had a stent or bypass. It aims to see which approach works better and is safer.
This trial tests whether taking two experimental drugs together can safely lower both high blood pressure and high cholesterol. It may be an option if you have both conditions and your blood pressure is not extremely high.
This trial tests a new combination pill for people with type 2 diabetes and high cholesterol who are already on metformin. It aims to see if the new drug helps control both blood sugar and cholesterol better than current treatments.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.